Biohaven Ltd. (BHVN) Earnings Per Share (EPS)
Biohaven Ltd. (BHVN) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2022-12-31 | -$12.75 |
| 2023-12-31 | -$5.73 |
| 2024-12-31 | -$9.28 |
| 2025-12-31 | -$6.86 |
How BHVN compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| NTLA | Intellia Therapeutics Inc. | -$3.81 |
| ENTA | Enanta Pharmaceuticals Inc. | -$3.84 |
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| RARE | Ultragenyx Pharmaceutical Inc. | -$5.83 |
| NKTR | Nektar Therapeutics | -$9.73 |
These are five companies in the same sector as BHVN with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Biohaven Ltd. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("BHVN")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BHVN | $15.69 | -0.32% | 2.68M |
| 3 | ||||
| 4 | ||||
| 5 |